Skip to content

Veracyte VCYT Cash Flow Statement

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
$88.01M+166%$66.35M+175%$30.32M+427%$26.34M+149%$33.05M+148%
$21.48M-7.5%$21.42M-8.7%$22.37M-5.0%$22.98M-8.0%$23.23M-11.0%
$45.4M+15.9%$43.6M+20.3%$42.33M+24.0%$40.32M+23.5%$39.19M+18.1%
$166.16M+85.8%$136.31M+81.5%$108.25M+63.7%$93.45M+85.7%$89.42M+139%
$10.82M-1.4%$9.68M-14.3%$10.04M+4.1%$9.49M-7.0%$10.97M-1.2%
-$108.43M-$110.97M
$77.03M$123.6M
$155.34M+98.0%$126.63M+98.5%$98.21M+73.9%$83.97M+109%$78.45M+198%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where does Veracyte's cash flow data come from?
Every line is extracted from Veracyte's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.